WHYJEMLDYOMJKO-HXUWFJFHSA-N
C31H34F5N5O3 — CID 146361499
Data last refreshed: (MolForge compound catalog, from PubChem)
About WHYJEMLDYOMJKO-HXUWFJFHSA-N
WHYJEMLDYOMJKO-HXUWFJFHSA-N (PubChem CID 146361499) has the molecular formula C31H34F5N5O3 and a molecular weight of 619.64 g/mol. Its IUPAC name is 3-(2-ethoxy-3-pyridinyl)-6-[(2R)-2-ethyl-4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-2-fluoro-N-[2-(methylamino)ethyl]benzamide.
Molecular Properties
| Compound Name | WHYJEMLDYOMJKO-HXUWFJFHSA-N |
|---|---|
| PubChem CID | 146361499 |
| Molecular Formula | C31H34F5N5O3 |
| Molecular Weight | 619.64 g/mol |
| Exact Mass | 619.26 |
| IUPAC Name | 3-(2-ethoxy-3-pyridinyl)-6-[(2R)-2-ethyl-4-[4-fluoro-2-(trifluoromethyl)benzoyl]piperazin-1-yl]-2-fluoro-N-[2-(methylamino)ethyl]benzamide |
| SMILES | CCOc1ncccc1-c1ccc(N2CCN(C(=O)c3ccc(F)cc3C(F)(F)F)C[C@H]2CC)c(C(=O)NCCNC)c1F |
| InChI | InChI=1S/C31H34F5N5O3/c1-4-20-18-40(30(43)23-9-8-19(32)17-24(23)31(34,35)36)15-16-41(20)25-11-10-21(22-7-6-12-39-29(22)44-5-2)27(33)26(25)28(42)38-14-13-37-3/h6-12,17,20,37H,4-5,13-16,18H2,1-3H3,(H,38,42)/t20-/m1/s1 |
| InChIKey | WHYJEMLDYOMJKO-HXUWFJFHSA-N |
| XLogP | 5.13 |
| TPSA | 86.80 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 619.64 |
| LogP ≤ 5 | 5.13 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146361499 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.